{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T05:22:48Z","timestamp":1766812968165,"version":"3.48.0"},"reference-count":51,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["23-15-00132"],"award-info":[{"award-number":["23-15-00132"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Yersinia pestis caused the three plague pandemics that claimed more than two hundred million human lives. There is still no vaccine that meets all WHO requirements, and many researchers continue to develop plague vaccines using various technological platforms. For example, researchers led by Roy Curtiss 3rd have developed a new approach to achieve controlled, delayed attenuation of bacterial pathogens. Mutants generated using this method were superior in protecting Y. pestis-infected mice immunized with strains generated using traditional gene knockout. However, further studies are needed to determine the safety and efficacy of these delayed-attenuated strains in other mammalian species in order to extrapolate on humans the data obtained in accordance with the FDA Animal Rule. Three Y. pestis strains, a \u0394crp mutant, a mutant with arabinose-dependent regulated crp expression (araC PBAD\u00a0crp) or an araC PBAD\u00a0crp mutant cured of plasmid pPst were derived from virulent wild-type strain 231. To evaluate the safety, outbred mice or guinea pigs were immunized subcutaneously with serial tenfold dilutions of mutated strains. For vaccine studies, immunized animals were subcutaneously challenged with 200 LD100 (lethal dose in all exposed subjects) of the wild-type Y. pestis strain. The challenge caused the death of 100% of na\u00efve animals in controls. The Y. pestis strain 231\u0394crp was nonlethal in mice at a dose of 107 CFs. The LD50 of the 231\u0394crp strain in guinea pigs increased by at least 107-fold compared to that of the wild-type strain. The LD50s of the 231PBAD-crp mutant in mice and guinea pigs were approximately 104-fold and 107-fold higher than those of Y. pestis 231, respectively. The 231PBAD-crp(pPst\u00af) strain did not cause death in mice (LD50 &gt; 107 CFU) and guinea pigs (LD50 &gt; 109 CFU) when administered subcutaneously and was capable of inducing intense protective immunity in both species of laboratory animals. Our research has shown once again the necessity of balance between safety and effectiveness demonstrating the feasibility of further investigation of crp mutants as promising candidate plague vaccines.<\/jats:p>","DOI":"10.3390\/biom16010040","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T02:07:58Z","timestamp":1766714878000},"page":"40","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Virulence Reduction in Yersinia pestis by Combining Delayed Attenuation with Plasmid Curing"],"prefix":"10.3390","volume":"16","author":[{"given":"Svetlana V.","family":"Dentovskaya","sequence":"first","affiliation":[{"name":"Laboratory for Plague Microbiology, Especially Dangerous Infections Department, State Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6985-6822","authenticated-orcid":false,"given":"Rima Z.","family":"Shaikhutdinova","sequence":"additional","affiliation":[{"name":"Laboratory for Plague Microbiology, Especially Dangerous Infections Department, State Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail E.","family":"Platonov","sequence":"additional","affiliation":[{"name":"Laboratory for Plague Microbiology, Especially Dangerous Infections Department, State Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8400-5276","authenticated-orcid":false,"given":"Nadezhda A.","family":"Lipatnikova","sequence":"additional","affiliation":[{"name":"Laboratory for Plague Microbiology, Especially Dangerous Infections Department, State Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0776-8392","authenticated-orcid":false,"given":"Elizaveta M.","family":"Mazurina","sequence":"additional","affiliation":[{"name":"Laboratory for Plague Microbiology, Especially Dangerous Infections Department, State Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tat\u2019yana V.","family":"Gapel\u2019chenkova","sequence":"additional","affiliation":[{"name":"Laboratory for Plague Microbiology, Especially Dangerous Infections Department, State Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1345-2033","authenticated-orcid":false,"given":"Pavel Kh.","family":"Kopylov","sequence":"additional","affiliation":[{"name":"Laboratory for Plague Microbiology, Especially Dangerous Infections Department, State Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergei A.","family":"Ivanov","sequence":"additional","affiliation":[{"name":"Laboratory for Plague Microbiology, Especially Dangerous Infections Department, State Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9223-2105","authenticated-orcid":false,"given":"Alexandra S.","family":"Trunyakova","sequence":"additional","affiliation":[{"name":"Laboratory for Plague Microbiology, Especially Dangerous Infections Department, State Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7280-3660","authenticated-orcid":false,"given":"Anastasia S.","family":"Vagaiskaya","sequence":"additional","affiliation":[{"name":"Laboratory for Plague Microbiology, Especially Dangerous Infections Department, State Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5499-7999","authenticated-orcid":false,"given":"Andrey P.","family":"Anisimov","sequence":"additional","affiliation":[{"name":"Laboratory for Plague Microbiology, Especially Dangerous Infections Department, State Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Zeppelini, C.G., De Almeida, A.M.P., and Cordeiro-Estrela, P. (2016). Zoonoses as Ecological Entities: A Case Review of Plague. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004949"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev.ento.50.071803.130337","article-title":"Natural History of Plague: Perspectives from More than a Century of Research","volume":"50","author":"Gage","year":"2005","journal-title":"Annu. Rev. Entomol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e00044-19","DOI":"10.1128\/CMR.00044-19","article-title":"Yersinia pestis: The Natural History of Plague","volume":"34","author":"Barbieri","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41541-023-00773-0","article-title":"Outlook of Pandemic Preparedness in a Post-COVID-19 World","volume":"8","author":"Williams","year":"2023","journal-title":"npj Vaccines"},{"key":"ref_5","first-page":"463","article-title":"Updated WHO List of Emerging Pathogens for a Potential Future Pandemic: Implications for Public Health and Global Preparedness","volume":"4","author":"Ukoaka","year":"2024","journal-title":"Infez. Med."},{"key":"ref_6","unstructured":"(2025, December 09). Pathogens Prioritization [Digest]. Available online: https:\/\/cdn.who.int\/media\/docs\/default-source\/consultation-rdb\/prioritization-pathogens-v6final.pdf?sfvrsn=c98effa7_9&download=true."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/1469-0691.12540","article-title":"Plague History: Yersin\u2019s Discovery of the Causative Bacterium in 1894 Enabled, in the Subsequent Century, Scientific Progress in Understanding the Disease and the Development of Treatments and Vaccines","volume":"20","author":"Butler","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/08830185.2015.1082177","article-title":"Anti-Infectious Human Vaccination in Historical Perspective","volume":"35","author":"Salemi","year":"2016","journal-title":"Int. Rev. Immunol."},{"key":"ref_9","unstructured":"Workshop WHO (2025, December 22). Efficacy Trials of Plague Vaccines: Endpoints, Trial Design, Site Selection. Available online: https:\/\/cdn.who.int\/media\/docs\/default-source\/blue-print\/plaguevxeval-finalmeetingreport.pdf?sfvrsn=c251bd35_2."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Lindler, L.E., Lebeda, F.J., and Korch, G.W. (2005). Plague Vaccines. Biological Weapons Defense, Humana Press.","DOI":"10.1385\/1592597645"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-94-024-0890-4_12","article-title":"Plague Vaccines: Status and Future","volume":"Volume 918","author":"Yang","year":"2016","journal-title":"Yersinia pestis: Retrospective and Perspective; Advances in Experimental Medicine and Biology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1007\/s00253-021-11389-6","article-title":"Plague Vaccines: New Developments in an Ongoing Search","volume":"105","author":"Rosenzweig","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1128\/IAI.00693-08","article-title":"Salmonella enterica Serovar Typhimurium Strains with Regulated Delayed Attenuation In Vivo","volume":"77","author":"Curtiss","year":"2009","journal-title":"Infect. Immun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1615\/CritRevImmunol.v30.i3.30","article-title":"New Technologies in Using Recombinant Attenuated Salmonella Vaccine Vectors","volume":"30","author":"Xin","year":"2010","journal-title":"Crit. Rev. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1128\/IAI.05526-11","article-title":"Live Attenuated Salmonella Vaccines Displaying Regulated Delayed Lysis and Delayed Antigen Synthesis to Confer Protection against Mycobacterium Tuberculosis","volume":"80","author":"Yang","year":"2012","journal-title":"Infect. Immun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/IAI.01122-09","article-title":"Yersinia pestis with Regulated Delayed Attenuation as a Vaccine Candidate to Induce Protective Immunity against Plague","volume":"78","author":"Sun","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/14740338.2018.1518429","article-title":"The FDA Animal Rule and Its Role in Protecting Human Safety","volume":"17","author":"Allio","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1155\/2012\/731604","article-title":"Advanced Development of the rF1V and rBV A\/B Vaccines: Progress and Challenges","volume":"2012","author":"Hart","year":"2012","journal-title":"Adv. Prev. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e01373-20","DOI":"10.1128\/mra.01373-20","article-title":"Whole-Genome Assembly of Yersinia pestis 231, the Russian Reference Strain for Testing Plague Vaccine Protection","volume":"10","author":"Kislichkina","year":"2021","journal-title":"Microbiol. Resour. Announc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1073\/pnas.120163297","article-title":"One-Step Inactivation of Chromosomal Genes in Escherichia coli K-12 Using PCR Products","volume":"97","author":"Datsenko","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0378-1119(95)00193-A","article-title":"Gene Disruption in Escherichia coli: TcR and KmR Cassettes with the Option of Flp-Catalyzed Excision of the Antibiotic-Resistance Determinant","volume":"158","author":"Cherepanov","year":"1995","journal-title":"Gene"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1128\/iai.59.12.4310-4317.1991","article-title":"Construction of an Eae Deletion Mutant of Enteropathogenic Escherichia coli by Using a Positive-Selection Suicide Vector","volume":"59","author":"Donnenberg","year":"1991","journal-title":"Infect. Immun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1590\/S1415-47572006000100024","article-title":"The pgm locus and pigmentation phenotype in Yersinia pestis","volume":"29","author":"Leal","year":"2006","journal-title":"Genet. Mol. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/jb.110.3.926-929.1972","article-title":"Gene Transfer in Pasteurella pestis Harboring the F\u2032 Cm Plasmid of Escherichia coli","volume":"110","author":"Lawton","year":"1972","journal-title":"J. Bacteriol."},{"key":"ref_25","unstructured":"Bahmanyar, M., and Cavanaugh, D.C. (1976). Plague Manual, World Health Organization (WHO)."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1128\/iai.31.2.839-841.1981","article-title":"Plasmids in Yersinia pestis","volume":"31","author":"Ferber","year":"1981","journal-title":"Infect. Immun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0147-619X(81)90019-6","article-title":"Essential Virulence Determinants of Different Yersinia Species Are Carried on a Common Plasmid","volume":"5","author":"Shafferman","year":"1981","journal-title":"Plasmid"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1128\/jb.148.3.877-883.1981","article-title":"Virulence-Associated Plasmids from Yersinia enterocolitica and Yersinia pestis","volume":"148","author":"Portnoy","year":"1981","journal-title":"J. Bacteriol."},{"key":"ref_29","first-page":"1081","article-title":"Detection and characterization of Yersinia pestis plasmids determining pesticin I, fraction I antigen, and \u201cmouse\u201d toxin synthesis","volume":"19","author":"Protsenko","year":"1983","journal-title":"Genetika"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1134\/S0003683819040082","article-title":"Characteristics of the Chromatographic Cleaning and Protectiveness of the LcrV Isoform of Yersinia pestis","volume":"55","author":"Kopylov","year":"2019","journal-title":"Appl. Biochem. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.17116\/molgen20244202110","article-title":"A Recombinant Low-Endotoxic Yersinia pseudotuberculosis Strain\u2014Over-Producer of Yersinia pestis F1 Antigen","volume":"42","author":"Trunyakova","year":"2024","journal-title":"Genet. Microbiol. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1128\/IAI.00976-09","article-title":"The smpB-ssrA Mutant of Yersinia pestis Functions as a Live Attenuated Vaccine to Protect Mice against Pulmonary Plague Infection","volume":"78","author":"Okan","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1128\/JB.01502-12","article-title":"Glucose Transport in Escherichia coli Mutant Strains with Defects in Sugar Transport Systems","volume":"194","author":"Steinsiek","year":"2012","journal-title":"J. Bacteriol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0749-0720(15)30008-6","article-title":"New Technology for Improved Vaccine Safety and Efficacy","volume":"17","author":"Roth","year":"2001","journal-title":"Vet. Clin. N. Am. Food Anim. Pract."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/ni1386","article-title":"Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response","volume":"7","author":"Montminy","year":"2006","journal-title":"Nat. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1016\/j.vaccine.2011.01.099","article-title":"A Live Attenuated Strain of Yersinia pestis KIM as a Vaccine against Plague","volume":"29","author":"Sun","year":"2011","journal-title":"Vaccine"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.1439793","article-title":"A surface protease and the invasive character of plague","volume":"258","author":"Sodeinde","year":"1992","journal-title":"Science"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Sebbane, F., Uversky, V.N., and Anisimov, A.P. (2020). Yersinia pestis Plasminogen Activator. Biomolecules, 10.","DOI":"10.3390\/biom10111554"},{"key":"ref_39","unstructured":"Anisimova, T.I., Sayapina, L.V., Sergeeva, G.M., Isupov, I.V., Beloborodov, R.A., Samoilova, L.V., Anisimov, A.P., Ledvanov, M.Y., Shvedun, G.P., and Zadumina, S.Y. (2002). Main Requirements for Vaccine Strains of the Plague Pathogen: Methodological Guidelines MU 3.3.1.1113-02, Federal Centre of State Epidemic Surveillance of Ministry of Health of Russian Federation."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/tmi.13865","article-title":"Vaccine Development for Bacterial Pathogens: Advances, Challenges and Prospects","volume":"28","author":"Mba","year":"2023","journal-title":"Trop. Med. Int. Health"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Anisimov, A.P., Vagaiskaya, A.S., Trunyakova, A.S., and Dentovskaya, S.V. (2025). Live Plague Vaccine Development: Past, Present, and Future. Vaccines, 13.","DOI":"10.3390\/vaccines13010066"},{"key":"ref_42","unstructured":"Korobkova, E.I. (1956). Live Antiplague Vaccine, Medgiz."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1128\/IAI.71.4.2234-2238.2003","article-title":"Synergistic Protection of Mice against Plague with Monoclonal antibodies Specific for the F1 and V Antigens of Yersinia pestis","volume":"71","author":"Hill","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1574-695X.1999.tb01229.x","article-title":"The SCID\/Beige Mouse as a Model to Investigate Protection against Yersinia pestis","volume":"23","author":"Green","year":"1999","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.micpath.2006.09.003","article-title":"Immunogenicity of the rF1+rV Vaccine for Plague with Identification of Potential Immune Correlates","volume":"42","author":"Williamson","year":"2007","journal-title":"Microb. Pathog."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Moore, B.D., Macleod, C., Henning, L., Krile, R., Chou, Y.-L., Laws, T.R., Butcher, W.A., Moore, K.M., Walker, N.J., and Williamson, E.D. (2022). Predictors of Survival after Vaccination in a Pneumonic Plague Model. Vaccines, 10.","DOI":"10.3390\/vaccines10020145"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e01054-24","DOI":"10.1128\/spectrum.01054-24","article-title":"Evaluation of Human Antibodies from Vaccinated Volunteers for Protection against Yersinia pestis Infection","volume":"12","author":"Zhang","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1600-065X.2008.00674.x","article-title":"Immune Defense against Pneumonic Plague","volume":"225","author":"Smiley","year":"2008","journal-title":"Immunol. Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1128\/IAI.00185-06","article-title":"Gamma Interferon, Tumor Necrosis Factor Alpha, and Nitric Oxide Synthase 2, Key Elements of Cellular Immunity, Perform Critical Protective Functions during Humoral Defense against Lethal Pulmonary Yersinia pestis Infection","volume":"74","author":"Parent","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"6866","DOI":"10.1016\/j.vaccine.2011.07.059","article-title":"T Cells Play an Essential Role in Anti-F1 Mediated Rapid Protection against Bubonic Plague","volume":"29","author":"Levy","year":"2011","journal-title":"Vaccine"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41541-024-00958-1","article-title":"Progress on the Research and Development of Plague Vaccines with a Call to Action","volume":"9","author":"Williamson","year":"2024","journal-title":"npj Vaccines"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/1\/40\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T05:21:05Z","timestamp":1766812865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/1\/40"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["biom16010040"],"URL":"https:\/\/doi.org\/10.3390\/biom16010040","relation":{},"ISSN":["2218-273X"],"issn-type":[{"type":"electronic","value":"2218-273X"}],"subject":[],"published":{"date-parts":[[2025,12,25]]}}}